Procter & Gamble Health share price
You have to be logged in to add this to Watchlist.- ₹5,065.25(0.88%)April 20, 2026 15:29:00 PM IST
- NSE
- BSE
- Vol : 41.53 K (NSE + BSE)Last 20 day avg : 21.15 K
Procter & Gamble Health is trading 0.88% upper at Rs 5,065.25 as compared to its last closing price. Procter & Gamble Health has been trading in the price range of 5,130.00 & 4,998.70. Procter & Gamble Health has given -11.11% in this year & 4.60% in the last 5 days. Procter & Gamble Health has TTM P/E ratio 31.99 as compared to the sector P/E of 25.29.The company posted a net profit of 77.59 Crores in its last quarter.Listed peers of Procter & Gamble Health include Sun Pharmaceutical Industries (-0.43%), Torrent Pharmaceuticals (0.15%), Dr Reddy's Laboratories (-0.48%).The Mutual Fund holding in Procter & Gamble Health was at 10.48% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Procter & Gamble Health was at 6.97% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Apr 20, 2026, 03:49 PM UTC
- BetaLow volatility0.25Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry3.10Annual dividends as a percentage of the stock price.
- P/BHigher than historical values15.45The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values28.29Price-to-earnings ratio based on trailing 12-month earnings
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bearish | 1,668.00 | -0.43 | 4,00,199.64 | 36.24 | 5.77 | 0.92 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 4,185.00 | 0.15 | 1,41,292.23 | 67.32 | 17.1 | 0.83 | 17.62 |
| Dr Reddy's Laboratories | Moderately Bearish | 1,229.50 | -0.48 | 1,02,318.12 | 18.63 | 3.14 | 0.63 | 2.34 |
| Cipla | Moderately Bearish | 1,228.55 | -0.79 | 99,240.13 | 22.95 | 3.87 | 0.87 | 0.81 |
| Divi's Laboratories | Neutral | 6,267.60 | 0.62 | 1,66,341.02 | 78.61 | 11.52 | 0.46 | 0.01 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-06 | Quarterly Results & Interim Dividend |
| 2025-11-05 | Quarterly Results & Interim Dividend |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-12 | Quarterly Results & Interim Dividend |
- IndustryBiotechnology & Drugs
- ISININE199A01012
- BSE Code500126
- NSE CodePGHL
Procter & Gamble Health is trading at 5065.25 as on Mon Apr 20 2026 09:59:00. This is 0.88% upper as compared to its previous closing price of 5021.30.
The market capitalization of Procter & Gamble Health is 8418.57 Cr as on Mon Apr 20 2026 09:59:00.
The 52 wk high for Procter & Gamble Health is 6638.95 whereas the 52 wk low is 4699.70
Procter & Gamble Health can be analyzed on the following key metrics -
- TTM P/E: 31.99
- Sector P/E: 25.29
- Dividend Yield: 3.09%
- D/E ratio: -
Procter & Gamble Health reported a net profit of 234.41 Cr in 2025.
The Mutual Fund Shareholding was 10.48% at the end of 31 Dec 2025.
EQUITY QUICK LINKS
Procter & Gamble Health QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.